1. Anti-infection NF-κB Apoptosis
  2. Bacterial IKK Ferroptosis
  3. Abietic acid

Abietic acid  (Synonyms: 松香酸)

目录号: HY-N6871 纯度: 93.93%
COA 产品使用指南

Abietic acid 是一种从松香中分离出来的口服有效的二萜,具有显著的抗增殖,抗炎,抗肥胖、抑菌,阻滞细胞周期和促凋亡活性。Abietic acid 抑制脂氧合酶活性用于过敏,Abietic acid 促进 HUVECs 细胞迁移和管状形成。Abietic acid 诱导显著的血管生成潜能,这与细胞外信号调节激酶 (ERK) 和 p38 表达上调有关。Abietic acid 通过抑制活化 B 细胞核因子 κB 轻链增强子 (NF-κB) 通路抑制 M1 巨噬细胞极化,减轻败血症诱导的肺损伤。Abietic acid 通过减轻炎症和铁死亡 (ferroptosis) 表现出对肝损伤的良好作用。Abietic acid 在小鼠皮肤伤口模型中显示加速伤口愈合。此外,Abietic acid 改善牛皮癣样炎症并调节小鼠肠道微生物群。Abietic acid 通过抑制 IKKβ 显著降低 NSCLC 细胞的增殖和生长。Abietic acid 有望用于非小细胞癌,肺损伤相关疾病和牛皮癣的研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Abietic acid Chemical Structure

Abietic acid Chemical Structure

CAS No. : 514-10-3

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 价格 是否有货 数量
10 mM * 1 mL in DMSO ¥500
In-stock
5 mg ¥500
In-stock
10 mg ¥775
In-stock
50 mg   询价  
100 mg   询价  

* Please select Quantity before adding items.

Customer Review

查看 IKK 亚型特异性产品:

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Abietic acid, an orally active diterpene isolated from Colophony, displays significant anti-proliferative, anti-inflammatory, anti-obesity effect, bacteriostatic, cell cycle arresting and pro-apoptotic activities. Abietic acid inhibits lipoxygenase activity for allergy. Abietic acid enhances cell migration and tube formation in HUVECs. Abietic acid induces significant angiogenic potential, which is associated with upregulation of extracellular signal-regulated kinase (ERK) and p38 expression. Abietic acid attenuates sepsis-induced lung injury by inhibiting nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway to inhibit M1 macrophage polarization. Abietic acid exhibits a positive effect against liver injury by attenuating inflammation and ferroptosis. Abietic acid shows accelerated wound closure in a mouse model of cutaneous wounds. Abietic acid significantly reduces the proliferation and growth of NSCLC cells by IKKβ inhibition.Additionally, Abietic acid ameliorates psoriasis-like inflammation and modulates gut microbiota in mice. Abietic acid is promising for research in non-small-cell lung cancer (NSCLC), liver injury-related deseases and psoriasis[1][2][3][4][5][6][7].

细胞效力
(Cellular Effect)
Cell Line Type Value Description References
A549 IC50
> 100 μM
Compound: 1
Cytotoxic activity against human A549 cells assessed as reduction in cell viability after 72 hrs by SRB assay
Cytotoxic activity against human A549 cells assessed as reduction in cell viability after 72 hrs by SRB assay
[PMID: 28011223]
HeLa CC50
14.9 μg/mL
Compound: 1
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
Cytotoxicity against human HeLa cells after 48 hrs by MTT assay
[PMID: 19217699]
PC-3 IC50
> 100 μM
Compound: 1
Cytotoxic activity against human PC3 cells assessed as reduction in cell viability after 72 hrs by SRB assay
Cytotoxic activity against human PC3 cells assessed as reduction in cell viability after 72 hrs by SRB assay
[PMID: 28011223]
SK-OV-3 IC50
90.4 μM
Compound: 1
Cytotoxic activity against human SKOV3 cells assessed as reduction in cell viability after 72 hrs by SRB assay
Cytotoxic activity against human SKOV3 cells assessed as reduction in cell viability after 72 hrs by SRB assay
[PMID: 28011223]
Vero CC50
52.5 μg/mL
Compound: 1
Cytotoxicity against african green monkey Vero cells after 48 hrs by MTT assay
Cytotoxicity against african green monkey Vero cells after 48 hrs by MTT assay
[PMID: 19217699]
体外研究
(In Vitro)

Abietic acid (0.8 μM, 24 小时) 抑制 HUVECs,NSCLC 和小鼠巨噬细胞的增殖,但在 HUVECs 里增加管的形成,细胞迁移和 p-p38,p-ERK 的表达水平[2][3][6]
Abietic acid (0-50 μM, 24 小时) 通过降低细胞周期相关蛋白的表达,有效地将细胞阻滞在 G0/G1 期[3]
Abietic acid (0-100 μM, 0.5 或 1 小时) 在 NSCLC 细胞中直接结合 IKKβ 并抑制 IKKβ/NF-κB 信号通路[3]
Acetaminophen (APAP) (HY-66005) (300 mg/kg, 腹腔注射, 13 小时) + abietic acid (10、20、40mg /kg, 腹腔注射, 13 小时) 组肝细胞结构与 APAP 组相似,炎症浸润面积和组织坏死明显减少,小鼠肝脏内核仁明显[5]
Abietic acid (20、40、80 μM, 13 小时) 显著抑制 APAP 诱导的肝细胞 TNF-α、IL-1β 的表达及 MDA 和 Fe2+ 的产生,但显著增加 Nrf2 和 HO-1 的表达[5]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay[2]

Cell Line: Human umbilical vein vascular endothelial cells (HUVECs)
Concentration: 0.4-25 μM
Incubation Time: 24 h
Result: Inhibited the proliferation of HUVECs in a dose-dependent manner.

Cell Migration Assay [2]

Cell Line: HUVECs
Concentration: 0.4 and 0.8 µM
Incubation Time: 24 h
Result: Resulted in HUVECs migration increases of 9.23 and 25.17% at 0.4 and 0.8 µM.

Cell Cycle Analysis[3]

Cell Line: NSCLC cells
Concentration: 0-50 μM
Incubation Time: 24 h
Result: Effectively arrested PC-9 and H1975 cells at the G0/G1 phase and down-regulated the expression of cyclin D1 and cdk4 in NSCLC cells.

Cell Viability Assay[6]

Cell Line: Mouse macrophages
Concentration: low concentrations (20, 40 and 80 µmol/L) and high concentrations (160 and 320 µmol/L)
Incubation Time: 26 h
Result: Decreased the viability of mouse macrophages at high concentrations and the concentration of IL-1β, TNF-α, IL-6 and MIP-2 which were induced by LPS in the cell culture medium of mouse macrophages.
体内研究
(In Vivo)

Abietic acid (0.8 µM, 每天处理一次,持续 10 天) 在雄性 ICR 小鼠皮肤创伤模型中显示加速伤口愈合[2]
Abietic acid (40 mg/kg, 腹腔注射, 6 or 24 小时) 提高小鼠存活率,减轻败血症引起的肺损伤[6]
Abietic acid (1.0 mg/kg, 口服, 每天一次,持续 7 天) 改善 imiquimod (IMQ) (HY-B0180) 诱导的牛皮癣样炎症症状,重建小鼠微生物群落组成[7]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male ICR mouse model of cutaneous wounds (4-5 weeks of age)[2]
Dosage: 0.8 µM
Administration: treat wound daily, captured images on day 0, 2, 4, 6, 8, and 10
Result: Had an effect on wound closure in male ICR mouse model of cutaneous wounds.
Animal Model: Male C57BL/6 mice (24-30 g, 8-10 weeks old)[6]
Dosage: 40 mg/kg
Administration: i.p., 6 or 24 h
Result: Improved survival and attenuated sepsis induced lung injury in mice.
Animal Model: IMQ-induced psoriasis-like inflammation mice (7 weeks old, 16-18 g)
Dosage: 1.0 mg/kg
Administration: p.o., daily for 7 days
Result: Attenuated the imiquimod-induced psoriasis-like lesions and decreased PASI score of skin lesions in mice.
分子量

302.45

Formula

C20H30O2

CAS 号
性状

固体

颜色

White to off-white

中文名称

松香酸

结构分类
初始来源
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
溶解性数据
细胞实验: 

DMSO 中的溶解度 : 100 mg/mL (330.63 mM; 超声助溶; 吸湿的 DMSO 对产品的溶解度有显著影响,请使用新开封的 DMSO)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 3.3063 mL 16.5317 mL 33.0633 mL
5 mM 0.6613 mL 3.3063 mL 6.6127 mL
查看完整储备液配制表

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

  • 摩尔计算器

  • 稀释计算器

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量
=
浓度
×
体积
×
分子量 *

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start)

C1

×
体积 (start)

V1

=
浓度 (final)

C2

×
体积 (final)

V2

动物实验:

请根据您的 实验动物和给药方式 选择适当的溶解方案。

以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用
以下溶剂前显示的百分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 方案 一

    请依序添加每种溶剂: 10% DMSO    40% PEG300    5% Tween-80    45% Saline

    Solubility: ≥ 2.5 mg/mL (8.27 mM); 澄清溶液

    此方案可获得 ≥ 2.5 mg/mL(饱和度未知)的澄清溶液。

    1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀;再向上述体系中加入 50 μL Tween-80,混合均匀;然后再继续加入 450 μL 生理盐水 定容至 1 mL

    生理盐水的配制:将 0.9 g 氯化钠,溶解于 ddH₂O 并定容至 100 mL,可以得到澄清透明的生理盐水溶液。
  • 方案 二

    请依序添加每种溶剂: 10% DMSO    90% (20% SBE-β-CD in Saline)

    Solubility: ≥ 2.5 mg/mL (8.27 mM); 澄清溶液

    此方案可获得 ≥ 2.5 mg/mL(饱和度未知)的澄清溶液。

    1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL 20% 的 SBE-β-CD 生理盐水水溶液 中,混合均匀。

    2 g SBE-β-CD(磺丁基醚 β-环糊精)粉末定容于 10 mL 的生理盐水中,完全溶解至澄清透明。
动物溶解方案计算器
请输入动物实验的基本信息:

给药剂量

mg/kg

动物的平均体重

g

每只动物的给药体积

μL

动物数量

由于实验过程有损耗,建议您多配一只动物的量
请输入您的动物体内配方组成:
%
DMSO +
+
%
Tween-80 +
%
Saline
如果您的动物是免疫缺陷鼠或者体弱鼠,建议 DMSO 中的在最后工作液体系中的占比尽量不超过 2%。
方案所需 助溶剂 包括:DMSO ,均可在 MCE 网站选购。 Tween 80,均可在 MCE 网站选购。
计算结果
工作液所需浓度 : mg/mL
储备液配制方法 : mg 药物溶于 μL  DMSO(母液浓度为 mg/mL)。
您所需的储备液浓度超过该产品的实测溶解度,以下方案仅供参考,如有需要,请与 MCE 中国技术支持联系。
动物实验体内工作液的配制方法 : 取 μL DMSO 储备液,加入 μL  μL ,混合均匀至澄清,再加 μL Tween 80,混合均匀至澄清,再加 μL 生理盐水
连续给药周期超过半月以上,请谨慎选择该方案。
请确保第一步储备液溶解至澄清状态,从左到右依次添加助溶剂。您可采用超声加热 (超声清洗仪,建议频次 20-40 kHz),涡旋吹打等方式辅助溶解。
纯度 & 产品资料

纯度: 93.93%

参考文献

完整储备液配制表

* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C储存时,请在6个月内使用,-20°C储存时,请在1个月内使用。

可选溶剂 浓度 溶剂体积 质量 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 3.3063 mL 16.5317 mL 33.0633 mL 82.6583 mL
5 mM 0.6613 mL 3.3063 mL 6.6127 mL 16.5317 mL
10 mM 0.3306 mL 1.6532 mL 3.3063 mL 8.2658 mL
15 mM 0.2204 mL 1.1021 mL 2.2042 mL 5.5106 mL
20 mM 0.1653 mL 0.8266 mL 1.6532 mL 4.1329 mL
25 mM 0.1323 mL 0.6613 mL 1.3225 mL 3.3063 mL
30 mM 0.1102 mL 0.5511 mL 1.1021 mL 2.7553 mL
40 mM 0.0827 mL 0.4133 mL 0.8266 mL 2.0665 mL
50 mM 0.0661 mL 0.3306 mL 0.6613 mL 1.6532 mL
60 mM 0.0551 mL 0.2755 mL 0.5511 mL 1.3776 mL
80 mM 0.0413 mL 0.2066 mL 0.4133 mL 1.0332 mL
100 mM 0.0331 mL 0.1653 mL 0.3306 mL 0.8266 mL
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
Abietic acid
目录号:
HY-N6871
需求量: